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Summary 
About two-thirds of the antibodies to the nicotinic ace- 
tylcholine (ACh) receptor in patients with the autoim- 
mune disease myasthenia gravis bind to the main im- 
munogenic region (MIR). This is a small, well-defined 
region on each of the two (~ subunits, containing resi- 
dues 67-76 (a67-76). By determining the structure of 
the ACh receptor complexed with two different frag- 
ments of an MIR-directed antibody, we have deter- 
mined the three-dimensional location of the MIR (and 
therefore residues a67-76) to be at the extreme synap- 
tic end of each a subunit. The antibody fragments ex- 
tend from the binding site away from the receptor axis 
and into the synaptic cleft, minimizing any steric inter- 
ference neighboring ACh receptors might have with 
their binding. 
Introduction 
The muscular weakness and fatigue that characterize my- 
asthenia gravis result from an antibody-mediated autoim- 
mune response against the nicotinic acetylcholine (ACh) 
receptors of the neuromuscular junction (reviewed in Conti- 
Tronconi et al., 1994, Protti et al., 1993). Serum antibodies 
cross-link ACh receptors in the postsynaptic membrane 
and, by doing so, increase their degradation rate (Drach- 
man et al., 1978; Pumplin and Drachman, 1983). Anti- 
bodies bound to ACh receptors may also activate the com- 
plement cascade (Tzartos et al., 1981). The result is a 
reduction in the number of receptors and an impairment 
of neuromuscular transmission. 
The serum antibodies to the ACh receptor are hetero- 
geneous, but about two-thirds of them bind to the main 
immunogenic region (MIR) (Tzartos et al., 1982), a small, 
well-defined region (Kordossi and Tzartos, 1989) on the 
extracellular part of the a subunit (Tzartos and Lindstrom, 
1980). Antibodies to the MIR are pathologically significant; 
monoclonal antibodies (MAbs) to the MIR can, for in- 
stance, passively transfer experimental autoimmune my. 
asthenia gravis in rats (Tzartos and Lindstrom, 1980). 
Because the MIR plays an important role in myasthenia 
gravis, much effort has been directed toward characteriz- 
ing the epitopes that compose it. These epitopes do not 
overlap with the ACh or bungarotoxin binding sites (Tzartos 
and Lindstrom, 1980; Tzartos et al., 1981). Many of the 
MIR-directed MAbs bind to the peptide corresponding to 
residues 67-76 of the a subunit. However, they bind more 
weakly to the peptide than to the native receptor; so, al- 
though the sequence (~67-76 forms a main constituent 
loop of the MIR, other residues either form part of the MIR 
or stabilize its native conformation (Barkas et al., 1988; 
Tzartos et al., 1988). Peptide binding studies also indicate 
that the MIR may consist of overlapping epitopes for differ- 
ent MAbs (Tzartos et al., 1990). The species cross- 
reactivity of MAbs to the MIR shows it to be highly con- 
served among muscle-type ACh receptors (Tzartos et al., 
1981); residues a67-76 are also highly conserved among 
species (Bellone et al., 1989). 
Most structural studies of the ACh receptor have used 
receptors derived from the electric organs of the electric 
ray Torpedo. These organs contain high densities of re- 
ceptor dimers that are organized in partly crystalline arrays 
(Chang and Bock, 1977; Heuser and Salpeter, 1979). Un- 
der certain conditions after isolation (Brisson and Unwin, 
1984; Kubalek et al., 1987), these dimers form ordered 
arrays on the surface of tubular vesicles, with their synap- 
tic ends pointing outward. Electron crystallographic stud- 
ies using flattened tubes preserved by either negative 
staining or rapid freezing show that the five subunits of 
the receptor are arranged in a pseudopentameric array 
around the central water-filled ion pathway (Brisson and 
Unwin, 1984; Brisson and Unwin, 1985; Mitra et al., 1989). 
The most detailed maps come from helical analyses of 
intact tubes that are rapidly frozen and then imaged by 
cryoelectron microscopy (Toyoshima and Unwin, 1988). 
Such analyses enable the averaging of information from 
the many receptors in the tubes while combining informa- 
tion from the different views available in a helix to obtain 
the three-dimensional structure. The subunits are 120 A 
long rods that fit into a cylinder 80 A in diameter and lie 
approximately perpendicular to the plane of the mem- 
brane. The ion pathway is narrow across the bilayer but 
widens outside it into a cylinder that is 20-25 ,~ in diameter 
and that extends 60-70 A toward the synapse and 15-20 
A toward the interior of the cell. An extra mass is attached 
to the receptor at its intracellular end. This is probably 
the 43 kDa protein (Toyoshima and Unwin, 1988), which 
colocalizes with the receptor (Sealock et al., 1984) in ap- 
proximately a 1:1 stoichiometry (LaRochelle and Froehner, 
1986). 
The location of the MIR in two dimensions was deter- 
mined in a study that used electron microscopic images 
of tubes flattened in negative stain (Kubalek et al., 1987). 
Projection maps of various receptor-label complexes were 
produced; the label used to locate the MIR was a Fab 
fragment of MAb35 (see below). Fab35 appeared to attach 
to the outer edge of the receptor, at sites rotated approxi- 
mately 36 ° relative to the a-bungarotoxin sites at the mid- 
dle of the a subunits. 
Although MAb35 was raised against ACh receptors from 
the electric eel, it cross-reacts with receptors from various 
sources (Tzartos et al., 1982). It binds strongly to the MIR 
on intact receptors (Tzartos et al., 1981), but does not bind 
significantly to peptides that correspond to residues a67- 
76 (Tzartos et al., 1988), Mutagenesis studies on native 
receptors (Saedi et al., 1990) and further peptide binding 
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studies (Papadouli et al., 1993) show, however, that it does 
bind to some of those residues in native receptors (e.g., 
a68 and ~71; Saedi et al., 1990). There is no indication 
that MAb35 directly interferes with receptor function (Lind- 
strom et al., 1981 ; Wan and Lindstrom, 1985), but it does 
cross-link ACh receptors in the postsynaptic membrane 
to increase their degradation rate (Conti-Tronconi et al., 
1981; Tzartos et al., 1981). MAb35 can passively induce 
experimental autoimmune myasthenia gravis, as can 
F(ab')235, a bivalent fragment of MAb35 that also cross- 
links receptors (Loutrari et al., 1992; Tzartos et al., 1987). 
Fab35, which protects receptors from being cross-linked 
byanti-MIR MAbs, can prevent 68% of the antigenic modu- 
lation caused by myasthenic patients' serum on muscle 
cells in culture (Tzartos et al., 1985). 
The localization of the MIR in three dimensions and the 
architectural details of the attachment should provide im- 
portant information about the interaction of pathologically 
significant antibodies with the ACh receptor. The localiza- 
tion of a67-76 in the receptor structure also places con- 
straints on how the protein folds. We have determined the 
three-dimensional location of the MIR and the nature of 
antibody attachment by electron microscopy of ACh recep- 
tor tubes labeled with Fab35 or scFv35 (which contains 
only the variable domain of Fab35; Marks, 1992). The anti- 
body fragments are found to bind to the extreme synaptic 
ends of the a subunits and to extend away from the recep- 
tor axis and toward the synaptic cleft. 
Results 
Preparations of ACh receptor-rich vesicles contain tubes 
of various diameters, each diameter corresponding to a 
different helical family and, therefore, a slightly different 
packing arrangement of the receptors (Toyoshima nd U n- 
win, 1990). scFv35 and Fab35 were incubated with these 
tubes in suspension before being applied to electron mi- 
croscope grids and examined by cryomethods (see Exper- 
imental Procedures). Images of 760 A diameter tubes 
((-16,6) helical family) and 750 A diameter tubes ((-15,5) 
helical family) were analyzed to determine the structures 
of the scFv35- and Fab35-1abeled receptors, respectively. 
Figure 1 shows images of scFv35-1abeled and Fab35- 
labeled tubes, together with unlabeled tubes of the same 
helical family as controls. The contrast in these images 
arises from the different densities of the protein (which 
appears dark) and the surrounding lipids and ice (which 
appear light). The synaptic ends of the closely packed 
receptors point outward (Brisson and Unwin, 1984), giving 
the edges of the tubes a striated appearance. The labeled 
tubes appear wider and more speckled than their unla- 
beled counterparts, owing to the presence of the antibody 
fragments. 
The determination ofthe structures from the images was 
done by Fourier methods (see Experimental Procedures) 
to a resolution of 20 A. The Fourier terms from three scFv35- 
labeled tubes and three Fab35-1abeled tubes were aver- 
aged (see Experimental Procedures) to determine the re- 
spective structures. Previously determined structures of 
Figure 1. Images of Labeled and Unlabeled ACh Receptor Tubes Em- 
bedded in Ice 
(a) scFv35-1abeled and unlabeled (control) tubes of the same diameter 
(helical family (-16,6)) and (b) Fab35-iabeled and control tubes of the 
same diameter (helical family (-15,5)). The synaptic ends of the closely 
packed receptors point outward, giving the edges of the tubes a stri- 
ated appearance. The labeled tubes appear more speckled and slightly 
wider, owing to the binding of the antibody fragments. The (-16,6) 
tube that was labeled with scFv35 fragments has a slightly greater 
diameter than the (-15,5) tube that was labeled with Fab35 fragments. 
Bar, 500 ,~,. 
the unlabeled receptors (Toyoshima nd U nwin, 1990; U n- 
win, 1993) were used as controls. Details of the images 
and averaged datasets are summarized in Table 1. 
Radial Density Distributions 
Distributions of density against distance from the tube 
axes were calculated from the three-dimensional datasets 
(see Experimental Procedures) and are shown in Figure 
2. The densities are lowest at radii of less than -150 A, 
at which they correspond to the ice that fills the tubes. They 
increase at higher radii ( -  150-400 A), owing to the pres- 
ence of protein. At even higher radii (>400 A), outside the 
tube, the densities decrease to the level of the ice. The 
density distributions of labeled and unlabeled (control) 
tubes are similar, except that the labeled tubes have extra 
shoulders of density (arrows) at high radii ( -  350-400 A). 
The shoulder is broader for the Fab35-1abeled tubes than 
for the scFv35-1abeled ones. These shoulders, which must 
be due to the antibody fragments, lie beyond the maximum 
radii of the unlabeled tubes, indicating that the antibody 
fragments attach to the end of the receptor. To determine 
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Table 1. Characteristics of Individual Images and Combined Datasets 
Number of Receptors Phase Residual" Weight in Final 
scFv35 
Film number 4280 3560 23.5 0.18 
Film number 4282 4360 24.2 0.23 
Film number 4295 4820 16.1 0.59 
Combined atasat 12,740 9.4 (1.0) 
Control 8500 19.4 
Fab35 
Film number 4906 2430 26.2 0.33 
Film number 5168 1700 28.6 0.33 
Film number 5381 2180 26.3 0.33 
Combined ataset 6310 19.9 (1.0) 
Control 9420 15.6 
a Amplitude-weighted phase residuals for 2-fold symmetry (difference from 0 ° or 180°). 
the precise locations and architectural details of the anti- 
body fragments, we next calculated and examined the three- 
dimensional maps. 
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Figure 2. Locations of Antibody Fragments in Radial Plots 
The graphs show how the density is distributed in labeled and unla- 
beled tubes as a function of radial distance from their axes. In both 
cases, the labeled tubes are compared with unlabeled tubes of the 
same diameter. The labeled tubes have extra shoulders of density at 
high radii (arrows). The shoulder on the Fab35-1abeled density distribu- 
tion is broader than the shoulder on the scFv35-1abeled one because 
Fab fragments are larger than scFv fragments. The shaded region 
corresponds to the radial extent of the receptors; the differences in 
density at lower radii (below - 250/~ for the scFv-labeled tubes and 
-225 ~, for the Fab-labeled tubes) may reflect different amounts of 
bound cytoplasmic proteins, including the 43 kDa protein (LaRochelle 
and Froehner, 1986). 
Antibody-Receptor Complexes 
Figure 3 shows the structures of the scFv35-1abeled and 
Fab35-1abeled tubes in cross-section. The receptors pro- 
ject - 60-70 A from the membrane surface, into the synap- 
tic cleft. The antibody fragments (shaded grey) give rise 
to densities that are not present in corresponding maps 
of unlabeled receptors (Figure 3, Control). The Fab frag- 
ments (Figure 3, Fab) look similar to the scFv fragments 
(Figure 3, scFv), except that they present extra densities 
(marked as C in Figure 3, Fab) that extend further from 
the tube axis. These extra densities appear to correspond 
to the constant domains of the Fab fragments (see below). 
Figure 4 shows the Fab35-1abeled receptors in three 
dimensions. Maps that represent the densities in unla- 
beled tubes subtracted from those in corresponding la- 
beled tubes show significant differences only in the region 
of the antibody fragments (data not shown), indicating that 
no major conformational change has occurred upon bind- 
ing. The antibody fragments extend into the synaptic cleft 
(upward in our nomenclature) from protrusions (see also 
Figures 12 and 13 of Toyoshima and Unwin, 1990) at the 
ends of the a subunits. The regions thought o correspond 
to the constant domains of the Fab fragments (stippled 
red and marked as C) lie above the variable domains 
(marked as V), which are identified by their matching ap- 
pearance to the scFv fragments (see 
Antibody Fragments 
Each antibody fragment mass connects equivalent a sub- 
units (i.e., c¢8-es and a~-cz~; see below) of neighboring re- 
ceptors, giving the impression that the antibody fragments 
cross-link neighboring receptors. This is the case for both 
scFv35-1abeled (Figure 5a) and Fab35-1abeled (Figure 5b) 
receptors. Both types of antibody fragment are monova- 
lent, however, so each mass should be composed of two 
fragments (V and C mark possible locations of variable 
and constant domains of individual antibody fragments; 
the constant domains are also stippled red), the densities 
having merged at this low resolution. The two sites on 
each receptor where the antibody fragments make contact 
are separated by about 144 ° around the central axis, which 
is the angle expected given that there is one subunit be- 
tween the ~ subunits and the receptor has pseudo-5-fold 
symmetry. 
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Figure 3. Antibody Fragments Attached to Receptors in Cross-Sections 
through the Tubes 
Maps are from a scFv35-1abeled tube (scFv35), a Fab35-1abeled tube 
(Fab), and an unlabeled (Control) tube of the same diameter as in scFv. 
The antibody fragments (shaded grey) are at the synaptic ends of the 
receptors, which extend -60-70 A above the lipid bilayer (phospho- 
lipid head groups indicated by dashed lines). Additional density associ- 
ated with the Fab fragments (marked as C) appears to correspond 
to their constant domains• The central ion pathways formed by the 
receptors are indicated by the arrows. The continuous contours indi- 
cate densities greater than that of water. Bar, 50 .~. 
Figure 4. Side View of Fab Fragments Attached to the MIR of the Re- 
ceptor 
The Fab fragments (gold) are at the extreme synaptic end of the recep- 
tor (blue), attached to the rim surrounding the ion pathway (arrows). 
The constant domains (stippled red and marked as C) of those Fab 
fragments lie on top of the variable domains (marked as V) so the 
antibody fragments project from the binding site toward the synaptic 
cleft. The dashed lines denote the phospholipid head groups in the 
bilayer and are separated by about 40 A. 
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Figure 5. Synaptic View of Receptors Labeled with scFv35 and Fab35 Fragments 
(a) scFv35; (b) Fab35. 
The antibody fragments (gold) attach to sites that are separated by -144 ° around the central axis of each receptor (blue). The Fab fragments 
show extra mass (stippled red) compared with the scFv fragments; this corresponds to the Fab fragment constant domains. Each antibody fragment 
mass seems to extend from one receptor to its neighbor, even though the fragments are monovalent. Therefore, ach mass spanning neighboring 
subunits must contain two fragments that are not resolved from each other (V marks each variable domain and C marks each constant domain). 
The two different arrangements of antibody fragments arise because the receptors are grouped in pairs related by 2-fold axes. Bar, 50 ,~. 
The two antibody fragment masses connected to one 
receptor appear different from each other. In the case of 
the scFv35 fragments, this can be seen especial ly clearly 
in contour maps that represent their densities in sections 
parallel to the tube axis (Figure 6a). Although all the frag- 
ments are identical, they are connected to different ~ sub- 
units of each receptor in nonequivalent positions in the 
crystal lattice (which is composed of dimers of receptors) 
and, therefore, pair in different ways. To distinguish be- 
tween the two antibody fragment masses, we identify the 
subunits they are bound to as a~ (the a that touches the 
5) and a~, based on the locations of the a and $ subunits 
determined previously (Kubalek et al., 1987; both a sub- 
units are labeled in Figure 6). 
Figure 6. Sections through scFv35 and Fab35 Fragments, Overlying the Receptors to Which They Are Attached 
(a) scFv35; (b) Fab35. 
The antibody fragment variable domains (black contours) are located just above the receptors (shaded grey). The variable domains of the Fab 
fragments appear similar to the corresponding scFv fragments. The Fab fragments also have constant domains (red contours) above their variable 
domains. The assignments a~ and a~ are as in Kubalek et al. (1987). Bar, 50/~. 
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Figure 7. Inferred Locations and Orientations of Individual Antibody Fragments Relative to the Underlying Receptors 
In (a), the atomic structure of the variable domain f a Fab fragment (taken from Lesk, 1991) was inserted into the outlines of the scFv35 fragments 
(taken from Figure 6a). The approximate space filled by each fragment iscolored yellow. Although each of the outlines represents two fragments 
bound to neighboring receptors, the yellow fills more than half the space inside. This suggests that the binding of one scFv sterically inhibits the 
binding of its neighbor. Nevertheless, the outlines represent both fragments because they represent an average over the two alternative binding 
possibilities. In (b), the dashed lines outline the Fab35 variable domains, and the solid lines outline the constant domains (both taken from Figure 
6b). Individual variable domains (marked as V) re colored yellow as in (a). Since the constant domain of a Fabfragment connects to the ends 
of both arms of its variable domain, the constant domain associated with each variable domain can be identified unambiguously (marked with 
red dots and as C). The variable domains project away from the central axis of the receptor, placing the two constant domains almost 100 A ap rt. 
An Fc fragment cannot link constant domains this far apart, which explains why MAb35 cannot cross-link the two a subunits in one receptor. Bar, 
50~. 
The densities associated with the receptor-contacting 
domains of the Fab fragments (the black contours in Figure 
6b) show similar features to those of the scFv fragments, 
identifying them unambiguously as the variable domains. 
The remaining densities in Figure 6b (red contours) must 
therefore correspond to the constant domains. The densi- 
ties associated with the pairs of a~- and as-bound Fab frag- 
ment constant domains look different from each other be- 
cause of their nonequivalent positions in the crystal attice. 
Discussion 
Location of the MIR 
The three-dimensional maps show that the antibody frag- 
ments attach to the xtreme synaptic end of each (z sub- 
unit. Therefore, this is the location of the MIR, which in- 
cludes residues 67-76 (T'zartos et al., 1988). The end of 
each a subunit forms a distinct protrusion that seems well 
separated from those of the neighboring subunits (Toyo- 
shima and Unwin, 1990), so other subunits do not seem 
to be directly involved in the binding site. Studies per- 
formed on hybrid receptors confirm that the MIR is wholly 
within the ~ subunit (Loutrari et al., 1992). 
This location of the MIR at the ends of the a subunits 
might be taken to be at odds with the results of a previous 
study (Kubalek et al., 1987), in which the antibody binding 
site appeared, in projection, to be near the interface be- 
tween each a and its neighboring subunit. In fact, the 
three-dimensional densities composing the Fab35-1abeled 
receptor, when projected down the receptor axis, look like 
the densities in the previous study. The projection view can 
be misleading, however, because the top of the receptor, 
which includes the MIR, is twisted by about 36 ° around 
the channel axis (half the width of a subunit) (Toyoshima 
and Unwin, 1990) with respect to the main body of the 
structure. 
The position of the MIR on a protrusion at the end of the 
a subunit is consistent with its previous characterization as 
a small, well-defined region (well defined in the sense that 
all antibodies that bind to it seem to compete with all other 
antibodies that bind to it) on the a subunit (Kordossi and 
Tzartos, 1989). The extreme end of the a subunit is also 
in the most accessible part of the ACh receptor, which 
is consistent with its being the most highly immunogenic 
region of the receptor (Tzartos et al., 1982). Maps in which 
the densities of unlabeled tubes were subtracted from 
those of the labeled tubes showed no significant differ- 
ences between the two, except in the regions where the 
antibody fragments bound. Therefore, the antibody frag- 
ments did not induce any conformational change that 
could be detected at 20 A resolution. Studies comparing 
ACh receptors that had been treated with MIR-directed 
Fabs and MAbs (including MAb35) to unlabeled ACh re- 
ceptors also did not observe any effect of the Fabs or MAbs 
on ligand binding or sodium conductance (Lindstrom et 
al., 1981; Wan and Lindstrom, 1985). Rather, MIR-directed 
antibodies induce myasthenia gravis by enhancing the 
degradation rates of postsynaptic ACh receptors (Drach- 
man et al., 1978; Pumplin and Drachman, 1983). 
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Antibody Fragment Structures 
Individual domains in the antibody fragments can be lo- 
cated by comparing the Fab35 and scFv35 structures. The 
antibody fragment densities in the scFv35 maps (the gold 
in Figure 5a and the black contours in Figure 6a) are com- 
posed only of the variable domains. Densities that closely 
correspond to these also appear in the Fab35 maps (the 
gold in Figure 4 and Figure 5b and the black contours in 
Figure 6b); hence the extra densities above the variable 
domains in the Fab35 maps must correspond to the con- 
stant domains (labeled red in Figure 4, Figure 5b, and 
Figure 6b). 
To illustrate better the likely interaction of the antibody 
fragments with the ACh receptor, the X-ray structure of 
the variable domain of a Fab fragment was aligned by eye 
into the densities of the scFv35 map (Figure 7a). This 
structure consists of two antiparallel ~-sheets (Lesk and 
Chothia, 1982), which appear as two arms that point away 
from the binding site. In the cases of both the ~8- and 
~-bound scFv35 fragments, one I~-sheet extends more 
than half the distance toward the equivalent binding site 
of the neighboring receptor, indicating it would sterically 
interfere with the binding of an antibody fragment o that 
receptor. This suggests that at most only half of the MIR 
sites are occupied in the tubes, and that the antibody frag- 
ment "pairs" visualized are simply averages of the alterna- 
tive occupancies. Indeed, the scFv fragments appear al- 
most twice as dense in the "overlap" region (see Figure 
6a), where there should always be density from one or 
other of the fragments, than they appear in regions where 
only one of the fragments would contribute density. Such 
observations of steric interference are unlikely to reflect 
the situation in vivo, in which the distribution of receptors 
is different. 
Orientation of Fab35 
The constant domains of the Fab fragments bound to the 
a~ subunits of neighboring receptors form the two lobes 
(red contours in Figure 6b) that lie above their variable 
domains. These lobes do not merge with each other as 
do the variable domains. Each lobe must therefore repre- 
sent the constant domain of only one Fab fragment. The 
constant domains of the Fab fragments bound to the ~y 
subunits of neighboring receptors also contribute extra 
density (red contours in Figure 6b), but do not form obvi- 
ously distinct lobes. Their density distributions (highest 
midway between the ~ subunits on neighboring recep- 
tors) also suggest that some steric interference might be 
involved. 
The constant domain of a Fab fragment is connected 
to the ends of both arms of its variable domain. For each 
of the a subunits, these arms project away from the re- 
ceptor axis (Figure 7a). So, the constant domain linked 
(through its variable domain) to each ct subunit must be 
the one that lies radially outward from that subunit (see 
Figure 7b). Based on these assignments, the elbow angles 
(which relate the orientations of the variable and constant 
domains) of both Fab35 fragments are about 130 °, 
The constant domains of the two Fab fragments bound 
to a single receptor are almost 100 A apart. An Fc fragment 
can only link Fab fragments that are about 50 A apart 
(Silverton et al., 1977). To attain this separation with the 
Fab fragments oriented as they are, their elbow angles 
would have to be close to 0 °, which is well outside the 
observed range (130°-180°; Lesk and Chothia, 1988; Sil- 
verton et al., 1977). This explains why MAb35 cannot 
cross-link the two a subunits in one ACh receptor (Conti- 
Tronconi et al., 1981)--it binds in the wrong orientation. 
If the Fab fragments of another antibody were to bind 
to the MIR in a different orientation so that their variable 
domains did not project almost directly away from the re- 
ceptor axis, their constant domains could come within 50 
A of each other. An Fc could link constant domains at this 
distance. MAbs to the MIR that bind to both ~ subunits 
on one receptor do exist (Conti-Tronconi et al., 1981). 
ACh receptors in postsynaptic membranes are often 
closely packed (Fertuck and Salpeter, 1976; Heuser and 
Salpeter, 1979). Antibodies like MAb35, which project up- 
ward from the MIR and therefore do not have to snuggle 
in between receptors, could bind to them with a minimum 
of steric interference. Efficient binding of this kind may 
be particularly effective at enhancing the ACh receptor 
degradation rates responsible for the symptoms of myas- 
thenia gravis. 
Conclusion 
The MIR, which contains residues ~67-76, is located at 
the extreme synaptic end of each a subunit of the ACh 
receptor. When bound to the MIR, the variable domains 
of MAb35 project almost directly away from the channel 
axis. This places the constant domains too far from the 
second MIR in the same receptor to allow cross-linking of 
the two ct subunits by one MAb35 to occur. An antibody 
that binds to the MIR with a different orientation, however, 
could easily cross-link the two a subunits. MAb35 can bind 
to receptors with a minimum of steric interference because 
it projects away from the receptors into the synaptic cleft. 
Experimental Procedures 
Electron Microscopy 
Vesicular crystals (tubes) of ACh receptors in their native lipids were 
prepared from electric organs of Torpedo marmorata s described 
(Unwin, 1993). Antibody fragments were added to the tube suspension 
at a concentration of0.1 p.g/ml (3.2 pM) for scFv35 labeling (scFv35 
fragments were generously provided by Dr. Cara Marks, now at the 
University of California t Berkeley) and 0.2 mg/ml (4 nM) for Fab35 
labeling (Fab35 fragments were generously provided by Dr. Jon Lind- 
strom, University of Pennsylvania). The suspensions were allowed to 
stand for 20 min to 3 hr at 4°C. Aliquots of 3 ~1 were then applied to 
the carbon side of holey carbon grids that had been recently glow- 
discharged with amylamine. Excess solution was blotted off from the 
grid side (Toyoshima, 1989), and the grids were plunged into liquid 
ethane slush to freeze the tubes rapidly in a thin film of amorphous 
ice. Grids were stored in liquid nitrogen until ready for use. 
This procedure for antibody labeling ave essentially the same pro- 
jection structure as obtained in an earlier study (Kubalek et al., 1987), 
in which nonspecific binding was minimized by applying Fab35 to the 
specimen on the microscope grid in the presence of cytochrome c.
This earlier study also showed that Fab35 binds to the MIR sites on 
the tubes with high occupancy, whereas other nonMIR-directed Fab 
fragments do not bind to them significantly. 
Grids were placed in a Philips EM420 microscope using Gatan cryo- 
holders and were kept below -160°C during microscopy. The micro- 
scope was equipped with a twin lens, a twin-bladed anticontaminator, 
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and a low dose kit. Coherent illumination was achieved by using a 
small second condenser aperture (50 p,m diameter) and by strongly 
exciting the first condenser lens. A thin foil objective aperture, 50 p.m 
in diameter, was always in place. The microscope was operated at 
120 kV. 
Thin, straight ubes that were suspended over holes in the carbon 
support film were imaged only if the ice appeared thick enough to 
make flattening unlikely, but thin enough to make the tubes easily 
visible. The search for such tubes was carried out in the defocused 
diffraction mode at a magnification of - 1000 x.  Images were recorded 
at a magnification of 36,000 x,  on Kodak SO-163 film, at low (<10 e-l,&. 2) 
doses. Specimen d rift was minimized by adjusting the heater control on 
the cryoholder. The film was developed for 12 min in D19 developer. 
Image Analysis 
Images of tubes were selected according to the criteria of Toyoshima 
and Unwin, 1990. Fab35-1abeled and scFv35-1abeled tubes had to be 
of the (-15,5) and (-16,6) helical families, respectively. Micrographs 
were digitized with a Joyce-Loebl flatbed microdensitometer (exten- 
sively modified in-house) using aol 0 p,m effective spot size and 7.5 rim 
step size (corresponding to 2.15 A on the specimen). Image defocuses 
ranged from 1.2 to 1.8 p.m. 
Regions of each image that included exact multiples of the repeat 
distance of a tube were boxed off and Fourier transformed (DeRosier 
and Moore, 1970). The alignment of the tube axis with respect to the 
box, the correction for tilt of the tube away from the plane normal to 
the electron beam, and the extraction of layer lines from the Fourier 
transforms were done as described (Unwin, 1993), except that the 
rotation angle of the helix axis with respect to the box was refined to 
0.01 o instead of 0.05 °. The layer-line data from two to seven stretches 
along each tube were collected independently in this way. Only data 
extending to about 20/~ resolution (within the first zero in the contrast 
transfer function) were used. 
The tubes exhibit 2-fold symmetry about various radial axes be- 
cause the repeating unit in the crystal lattice is a dimer of receptors. 
All the datasets from all the regions of Fab35-1abeled tubes were 
brought to a common 2-fold phase origin and radial scale (the same 
origin and scale used in Toyoshima and Unwin, 1988); the same was 
done with all the datasets from the scFv35-1abeled tubes (to the origin 
and scale used in Unwin, 1993). Layer lines from Fab35-1abeled tubes 
were reassigned to obey the common helical selection rule I = 3n + 
67m (n = 5n'); layer lines from scFv35-1abeled tubes were reassigned 
to obey the rule I = -81n + 253m (n = 2n~ (Unwin, 1993). The different 
datasets were then averaged, weighting each dataset o maximize the 
5-fold rotational symmetry (judged by eye) of the receptor within the 
membrane. Equatorial terms were averaged separately as in Unwin 
(1993). The features seen in maps of the averaged datasets were also 
seen in the maps of the individual datasets, but with more noise. The 
final maps were calculated by a Fourier-Bessel synthesis of the aver- 
aged datasets after data that was inconsistent with the 2-fold symmetry 
of the crystal had been filtered out. The appearance of the maps was 
not significantly altered by correcting for the contrast ransfer function, 
so only the equators were corrected (assuming 7% amplitude contrast; 
Toyoshima and Unwin, 1988). Radial density distributions were deter- 
mined by a Fourier-Bessel synthesis of only the equatorial data. 
Control datasets were obtained from a similar analysis of three unla- 
beled (-15,5) and four unlabeled (-16,6) tubes (Toyoshima and Unwin, 
1990; Unwin, 1993). 
Surfaces of labeled receptors were rendered with AVS, using a thresh- 
old at which they would contain approximately 80%-1000/o of the vol- 
ume of the receptor. 
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